WHO 1st data call for products in the pre-clinical antibacterial pipeline

To better understand the current pre-clinical antibacterial R&D landscape WHO is undertaking a review of all products in the pre-clinical pipeline to tackle resistant infections. Companies, institutions and individuals are invited to submit data on their products that are in the pre-clinical pipeline targeting the WHO Priority Pathogens List, TB and C. difficile. The deadline for submission is 18 March 2019.

Article: WHO

Effective Surveillance  

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed